tirzepatide label Nomida 3ml Vial – iPackage hormone GLP Prescription Label, Editable Prescription Label,

However, research suggests that tirzepatide may lead to greater average weight reduction, as shown in a major tirzepatide weight loss clinical trial

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound) in adults with BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity

This is where a whole-person approach matters

We integrate GLP-1 management into primary care, tailoring treatment to each patient's full health picture and providing the ongoing support that drives real, sustainable results." Now available nationwide where One Medical has offices, the program offers in-person and remote visits, in-office labs for GLP-1 screening, and healthcare professionals who help with holistic weight loss plans and comorbidities

Unlike statins, which can cause myopathy through effects on muscle cell membranes and mitochondrial function, GLP-1 agonists do not have a known direct myotoxic mechanism